NCT07473648 Multimodal Clinical Study of Electroconvulsive Therapy and Magnetic Seizure Therapy
| NCT ID | NCT07473648 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The Second Hospital of Anhui Medical University |
| Condition | Electroconvulsive Therapy |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2025-09-01 |
| Primary Completion | 2027-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2025-09-01 with a primary completion date of 2027-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To compare the efficacy and tolerability of Electroconvulsive Therapy (ECT) and Magnetic Seizure Therapy (MST) in patients with major depressive disorder (MDD).
Eligibility Criteria
Inclusion Criteria: * Aged 12-80 years; * Diagnosis confirmed by two psychiatrists per DSM-5; * Stable medication regimen pre-enrollment; * Indicated for neuromodulation OR with visual field defects. Exclusion Criteria: * Major systemic diseases; * Prior neuromodulation within 3 months; * Pregnancy or potential pregnancy; * Metal implants or claustrophobia.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07473648 clinical trial?
This trial is open to participants of all sexes, aged 12 Years or older, up to 80 Years, studying Electroconvulsive Therapy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07473648 currently recruiting?
Yes, NCT07473648 is actively recruiting participants. Contact the research team at zylykd@163.com for enrollment information.
Where is the NCT07473648 trial being conducted?
This trial is being conducted at Hefei, China.
Who is sponsoring the NCT07473648 clinical trial?
NCT07473648 is sponsored by The Second Hospital of Anhui Medical University. The trial plans to enroll 200 participants.